Pagina 1 van 17

Publicaties afdeling neurologie / KNF VU medisch centrum 2007 Dissertaties: Bastos Leite AJ. Pathological ageing of the brain: a neuroimaging perspective. Vrije Universiteit Amsterdam 16 november 2007. promotoren:F Barkhof, Ph Scheltens Eikelenboom MJ. Biological markers in multiple sclerosis related to disease activity and progression. Vrije Universiteit Amsterdam 12 januari 2007. promotoren: CH Polman, copromotoren: J Killestein, BMJ Uitdehaag de Groot, V. Outcome measurement and functional prognosis in early multiple sclesosis. Vrije Universiteit Amsterdam 5 oktober 2007. promotoren: LM Bouter. GJ Lankhorst, CH Polman, copromotor: H Beckerman Jones BF. Cingulate cortex networks. Role in learning and memory and Alzheimer’s disease related changes. Vrije Universiteit Amsterdam 23 maart 2007. promotoren: Ph Scheltens, MP Witter Pijnenburg YAL. Frontotemporal dementia; towards an early diagnosis. Vrije Universiteit Amsterdam 5 juli 2007. promotoren: Ph Scheltens, C Jonker van de Pol LA. Hippocampal atrophy on MRI from aging to dementia; a clinical perspective. Vrije Universiteit Amsterdam11 mei 2007 promotoren: Ph Scheltens, F. Barkhof, copromotor: WM van der Flier Riemersma RF. Keep it bright: deterioration and reactivation of the biological clock in dementia Universiteit van Amsterdam 5 juli 2007. promotor: DF Swaab, copromotor: EJW van Someren Visschedijk MAJ. Evaluation of a psychosocial intervention program for patients with multiple sclerosis. Vrije Universiteit Amsterdam 28 juni 2007 promotoren: HM van der Ploeg, CH Polman, copromotor: EH Collette Winogrodzka A. Parkinson’s disease, monitoring early diagnosis and disease progression. Vrije Universiteit Amsterdam 8 november 2007 promotoren: E Ch Wolters, copromotor: RC Wagenaar Wetenschappelijke publicaties (Referee systeem): Aujard F, Cayetanot F, Terrien J, van Someren EJW. Attenuated effect of increased daylength on acitivity rhythm in the old mouse lemur, a non-human primate. Exp Gerontol 2007;42:1079-1087. Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O’Connor PW, Phillips JT, Polman CH, Radue E-W, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, for the AFFIRM and SENTINEL Investigators. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 2007;68:1299-1304. Barkhof F, Polman CH, Radue E-W, Kappos L, Freedman MS, Edan G, Hartung H-P, Miller DH, Montalban X, Poppe P, de Vos M, Lasri F, Bauer L, Dahms S, Wagner K, Pohl C, Sandbrink R. Magnetic resonance imaging effects of interferon Beta-1b in the BENEFIT study. Arch Neurol 2007;64:1292-1298. Barkhof F, Polvikoski TM, van Straaten ECW, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T. The significance of medial temporal lobe atrophy: a postmortem

Pagina 2 van 17

MRI study in the very old. Neurology 2007;69:1521-1527. Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging 2007;28:20-28. Bastos-Leite AJ, van der Flier WM, van Straaten ECW, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007;38:3182-3185. Battistin L, Korczyn AD, Wolters ECh. Historical overview of the WFN-organised Congresses on Parkinson’s disease and related disorders. Parkinsonism Relat Disord 2007;13(suppl.3): S205-S207. Proceedings of the XVII WFN World Congress on Parkinson’s disease and Related Disorders 9-13 December 2007. Amsterdam, The Netherlands. van Berckel BNM, Scheltens P. Getting a grip on Alzheimer’s disease: imaging amyloid in the brain. Lancet Neurol 2007;6:204-206. Berendse HW, Stam CJ. Stage-dependent patterns of disturbed neural synchrony in Parkinson’s disease. Parkinsonism Relat Disord 2007;13(suppl.3): S440-S445. Proceedings of the XVII WFN World Congress on Parkinson’s disease and Related Disorders 9-13 December 2007. Amsterdam, The Netherlands. Bö L, Geurts JJG, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in mutliple sclerosis. Arch Neurol 2007;64:76-80. Boesveldt S, Haehner A, Berendse HW, Hummel T. Signal-to-noise ration of chemosensory event-related potentials. Clin Neurophysiol 2007;118:690-695. Boonstra AM, Kooij JJS, Oosterlaan J, Sergeant JA, Buitelaar JK, van Someren EJW. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 2007;30:433-442. Bosma I, Vos MJ. Heimans JJ, Taphoorn MJB, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ, Klein M. The course of neurocognitive functioning in high-grade glioma patients. Neuro-oncol 2007;9:53-62. Bouwman FH, Schoonenboom SNM, van der Flier WM, van Elk EJ, Kok A, Barkhof F, Blankenstein MA, Scheltens Ph. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging 2007;28:1070-1074. Bouwman FH, van der Flier WM, Schoonenboom NSM, van Elk EJ, Kok A, Rijmen F, Blankenstein MA, Scheltens P. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007; 69:1006-1011. de Bruin AM, van Rossum AC, Visser MC, Koole GM. Modeling the emergency cardiac in-patient flow: an application of queuing theory. Health Care Manag Sci 2007;10:125-137. Calabresi PA, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, Hutchinson M, Kappos L, Miller DH, O’Connor PW, Phillips JT, Polman CH, Radue E-W, Rudick RA, Stuart WH, Lublin FD, Wajgt A, Weinstock-Gutttman B, Wynn DR, Lynn F, Panzara MA for the AFFIRM and SENTINEL. The incidence and significance of anti-natalizumab antibodies. Results from AFFIRM and SENTINEL. Neurology 2007;69:1391- 1403 .

Pagina 3 van 17

Carvalho-Bos SS, Riemersma-van der Lek RF, Waterhouse J, Reilly T, van Someren EJW. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry 2007;15:92-100. Cordonnier C, van der Flier WM, Sluimer JD, Barkhof F, Scheltens P. Reply: Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2007;68:391. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack Jr CR, Scheltens P, for the Alzheimer’s Disease Cooperative Study Group. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007;64:108-115. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 2007;6:734-746. van Es ACGM, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen ELEM, Middelkoop HAM, Weverling-Rijnsburger AWE, van der Grond J, Westendorp RGJ, van Buchem MA. Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. AJNR Am J Neuroradiol 2007;28:1938-1942. Ewers M, Buerger K, Teipel SJ, Scheltens P, Schröder J, Zinkowski RP, Bouwman FH, Schönknecht P, Schoonenboom NSM, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H. Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology 2007;69:2205-2212. Fabriek BO, Møller HJ, Vloet RPM, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BMJ, van den Berg TK, Dijkstra CD. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmnol 2007;187:179-186. Ferri R, Rundo F, Bruni O, Terzano MG, Stam CJ. Small-world network organization of functional connectivity of EEG slow-wave activity during sleep. Clin Neurophysiol 2007;118:449-456. van der Flier WM, Staekenborg S, Pijnenburg YAL, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 2007;23:42-46. van der Flier WM, Schoonenboom NSM, Pijnenburg YAL, Fox NC, Scheltens P. The effect of APOE genotype on clinical phenotype in Alzheimer disease.(Reply from the Authors) Neurology 2007;68:624. van der Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 2007;1097:215-224. Gootjes L, Scheltens P, van Strien JW, Bouma A. Subcortical white matter pathology as a mediating factor for age-related decreased performance in dichotic listening. Neuropsychologia 2007;45:2322-2332. Hachinski V, Skoog I, Scheltens P, Wallin A, Erkinjuntti T, Nagata K, Pasquier F, Breteler MMB, DeCarli C, Kalaria RN, Li Hsian CC, Royall DR, Román GC. Declaration of San Antonio, Texas, San Antonio, Tex., July 14, 2007. Neuroepidemiology 2007;28 : 191-192. Hagenbeek RE, Rombouts SARB, Veltman DJ, van Strien JW, Witter MP, Scheltens P, Barkhof F.

Pagina 4 van 17

Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging study. AJNR Am J Neuroradiol 2007;28:1715-1721. van Harten B, Oosterman JM, Potter van Loon B-J, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70-74. van Harten B, Oosterman J, Muslimovic D, Potter van Loon B-J, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170. Hartung H-P, Polman C, Bertolotto A, Deisenhammer F, Giovannoni G, Havrdova E, Hemmer B, Hillert J, Kappos L, Kieseier B, Killestein J, Malcus C, Comabella M, Pachner A, Schellekens H, Sellebjerg F, Selmaj K, Soelberg Sorensen P. Neutralising antibodies to interferon β in multiiple sclerosis: expert panel report. J Neurol 2007;254:827-837. van der Heijden KB, Smits MG, van Someren EJW, Ridderinkhof KR, Gunning WB. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 2007;46:233-341. Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O’Brien J, Barkhof F, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Pantoni L, for the LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes. Arch Intern Med 2007;167:81-88. Jasperse B, Minneboo A, de Groot V, Kalkers NF, van Helden PE, Uitdehaag BMJ, Barkhof F, Polman CH. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Arch Neurol 2007;64:190-194. Jasperse B, Valsasina P, Neacsu V, Knol DL, De Stefano N, Enzinger C, Smith SM, Ropele S, Korteweg T, Giorgio A, Anderson V, Polman CH, Fillippi M, Miller DH, Rovaris M, Barkhof F, Vrenken H, on behalf of the Magnetic Imaging in Multiple Sclerosis (MAGNIMS) study group. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX. J Magn Reson Imaging 2007;26:881-885. Jasperse B, Jakobs C, Eikelenboom MJ, Dijkstra CD, Uitdehaag BMJ, Barkhof F, Polman CH, Teunissen CE. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry. J Neurol 2007;254:631-637. Jasperse B, Vrenken H, Sanz-Arigita E, de Groot V, Smith SM, Polman CH, Barkhof F. Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. Neuroimage 2007;38:529-537. Jimenez CR, Koel-Simmelink M, Pham TV, van der Voort L, Teunissen CE. Endogenous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: optimization of magnetic bead-based peptide capture and analysis of preanalytical variables. Proteomics Clin Appl 2007;1:1385-1392. Jokinen H, Ryberg C, Kalska H, Ylikoski R, Rostrup E, Stegmann MB, Waldemar C, Madureira S, Ferro JM, van Straaten ECW, Scheltens P, Barkhof F, Fazekas F, Schmidt R, Carlucci G, Pantoni L, Inzitari D, Erkinjuntti T, on behalf of the LADIS group. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS study. J Neurol Neurosurg Psychiatry 2007;78:491-496. Jones BF, Witter MP. Cingulate cortex projections to the parahippocampal region and hippocampal formation in the rat. Hippocampus 2007;17:957-976.

Pagina 5 van 17

de Jong D, Jansen RWMM, Pijnenburg YAL, van Geel WJA, Borm GF, Kremer HPH, Verbeek MM. CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry 2007;78:936-938. Kalkers NF, Strijers RLM, Jasperse MMS, Neacsu V, Geurts JJG, Barkhof F, Polman CH, Stam CJ. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI. Clin Neurophysiol 2007;118:1332-1340. Kappos L, Freedman MS, Polman Ch, Edan G, Hartung H-P, Miller DH, Montalbán X, Barkhof F, Radü E-W, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R, for the BENEFIT Study Group. Effects of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007;370:389-397. Kappos L, Bates D, Hartung H-P, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O’Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007;6:431-441. Kappos L, Montalban X, Hartung H-P, Freedman M, Polman C; for the BENEFIT Steering Committee. Authors' reply: Treating clinically isolated syndromes suggestive of MS Lancet 2007;370:2000-2001. Kappos L, Polman CH, Freedman MS, Edan G. Hartung H-P, Miller DH, Montalban X, Barkhof F, Bauer L, Pohl C, Sandbrink R, for the BENEFIT Study Group. Reply: Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2007;68:1163-1164. Karas G, Scheltens P, Rombouts S, van Schijndel R, Klein M, Jones B, van der Flier W, Vrenken H, Barkhof F. Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study. Neuroradiology 2007;49:967-976. Killestein J, Polman CH. Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective ? Int MS J 2007;14:39-40. Kobelt G, Berg J, Lindgren P, Anten B, Ekman M, Jongen PJH, Polman C, and Uitdehaag B. Costs and quality of life in mutliple sclerosis in The Netherlands. Erratum to: Eur J Health Econ (2006)7:S55-S64. Eur J Health Econ 2007;8:359. Korf ESC, van Straaten ECW, de Leeuw F-E, van der Flier WM, Barkhof F, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund L-O, Rostrup E, Schmidt R, Fazekas F, Scheltens P, on behalf of tle Ladis Study Group. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007;24:166-171. Korteweg T, Uitdehaag BMJ, Knol DL, Smithuis RHM, Algra PR, de Vries C, Poppe PA, van Waesberghe JHTM, Bergers E. Lycklama à Nijeholt GJ, Polman CH, Barkhof F. Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol 2007;17:67-71. Kropholler MA, Boellard R, van Berckel BNM, Schuitemaker A, Kloet RW, Lubberink MJ, Jonker C, Scheltens P, Lammertsma AA. Evaluation of reference regions for (R)-[11 C]PK11195 studies in Alzheimer’s disease and mild cognitive impairment. J Cereb Blood Flow Metab 2007;27:1965-1974. Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung H-P, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007 Jan 25;356:371-378.

Pagina 6 van 17

Liedorp M, Sanchez E, van Hoogstraten IMW, von Blomberg BME, Barkhof F, Polman CH, Killestein J. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up. J Neurol Neurosurg Psychiatry 2007;78:1146-1148. Mandl ES, Buis DR, Heimans JJ, Peerdeman SM. Acquired encephaloceles and epilepsy in osteopetrosis. Acta Neurochir (Wien) 2007;149:79-81. Miller DH, Soon D, Fernando KT, MacManus DG, Barker GJ, Yousry TA, Fisher E, O’Connor PW, Phillips JT, Polman CH, Kappos L, Hutchinson M, Havrdova E, Lublin FD, Giovannoni G, Wajgt A, Rudick R, Lynn F, Panzara MA, Sandrock AW, for the AFFIRM Investigators (waaronder: Polman C, Zwemmer J, Nielsen J, Kalkers N, Kragt J, Jasperse B). MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 2007;68:1390-1401. Mulder C, van der Flier WM, Veerhuis R, Bouwman F, Jakobs C, Verhoeven NM, Barkhof F, Scheltens P, Blankenstein MA. Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism. J Am Geriatr Soc 2007;55:956-958. Nielsen JM, Moraal B, Polman CH, Poppe P, de Vos M, Freedman MS, Kappos L, Barkhof F, Bauer L, Pohl C, Sandbrink R, Hartung H-P, Uitdehaag BMJ. Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results. Mult Scler 2007;13:717-721. Nielsen JM, Korteweg T, Polman CH. Diagnosing MS: recent guidelines and future goals focusing on magnetic resonance imaging. Int MS J 2007;14:29-34. Niermeijer JMF, Somers M, Spliet W, Reijneveld JC, Biessels GJ. Rapidly progressive coma, hydrocephalus and leukoencephalopathy as presenting features of leptomeningeal metastases. J Neurol 2007;254:1757-1758. van Nieuwenhuizen D, Klein M, Stalpers LJA, Leenstra S, Heimans JJ, Reijneveld JC. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 2007;84:271-278. Oei NYL, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JPA, Veltman DJ, Scheltens P, Rombouts SARB. Glucocorticoids decrease hippocampal and prefrontal activation during declarative memory retrieval in young men. Brain Imaging and Behavior 2007;1:31-41. Parker KP, Bailey JL, Rye DB, Bliwise DL, van Someren EJW. Lowering dialysate temperature improves sleep and alters nocturnal skin temperature in patients on chronic hemodialysis. J Sleep Res 2007;16:42-50. Pettersson A, van Winsen L, van Oosten B, Kramers C, van de Ven A, Savelkoul P, van Agtmael M. Whipple’s disease in mentally retarded patients: report of two cases. Scand J Infect Dis 2007;39:1071-1073. Pijnenburg YAL, Janssen JC, Schoonenboom NSM, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE. CSF Neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Dement Geriatr Cogn Disord 2007;23:225-230. Pijnenburg YAL, Schoonenboom SNM, Mehta PD, Mehta SP, Mulder C, Veerhuis R, Blankenstein MA, Scheltens P. Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2007;78:735-737.

Pagina 7 van 17

Pijnenburg YAL. The roots of social inappropriateness in frontotemporal dementia. J Neurol Neurosurg Psychiatry 2007;78:441. Podewils LJ, Guallar E, Beauchamp N, Lyketsos CG, Kuller LH, Scheltens P. Physical activity and white matter lesion progression: assessment using MRI. Neurology 2007;68:1223-1226. van de Pol LA, van der Flier WM, Korf ESC, Fox NC, Barkhof F, Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 2007;69:1491-1497. van de Pol LA, Barnes J, Scahill RI, Frost C, Lewis EB, Boyes RG, van Schijndel RA, Scheltens P, Fox NC, Barkhof F. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration, Neuroimage 2007;34:1036-1041. van de Pol LA, Korf ESC, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007;64:1023-1028. Polman CH, Montalban X. Introduction. J Neurol 2007;254(suppl.1):I/1-I/2. Polman CH, Deisenhammer F, Giovannoni G, Killestein J, Schellekens H. To the editor:Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007;69:1553-1554. Polman CH, Montalban(Eds). New insights into the pathology of multiple sclerosis. J Neurol 2007;254(suppl.1):62 pp. Ponten SC, Kwee ML, Wolters ECh, Zijlmans JCM. First case of ataxia with isolated vitamin E deficiency in the Netherlands. Parkinsonism Relat Disord 2007;13:315-316. Ponten SC, Bartolomei F, Stam CJ. Small-world networks and epilepsy: graph theoretical analysis of intracerebrally recorded mesial temporal lobe seizures. Clin Neurophysiol 2007;118:918-927. Ramakers IHGB, Visser PJ, Aalten P, Boesten JHM, Metsemakers JFM, Jolles J, Verhey FRJ. Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord 2007;24:300-306. Raymann RJEM, Swaab DF, van Someren EJW. Skin temperature and sleep-onset latency: changes with age and insomnia. Physiol Behav 2007;90:257-266. Raymann RJEM, van Someren EJW. Time-on-task impairment of psychomotor vigilance is affected by mild skin warming and changes with aging and insomnia. Sleep 2007;30:96-103. Reijneveld JC, Ponten SC, Berendse HW, Stam CJ. The application of graph theoretical analysis to complex networks in the brain. Clin Neurophysiol 2007;118:2317-2331. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, ICTUS study group. The ICTUS study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 2007;29:29-38. Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P,

Pagina 8 van 17

Fox NC. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch Neurol 2007;64:849-854. Rombouts SARB, Scheltens P, Kuijer JPA, Barkhof F. Whole brain analysis of T2* weighted baseline FMRI signal in dementia. Hum Brain Mapp 2007;28:1313-1317. Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue E-W, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, for the AFFIRM and SENTINEL Investigators. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol 2007;62:335-346. Ryberg C, Rostrup E, Stegmann MB, Barkhof F, Scheltens P, van Straaten ECW, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund L-O, O’Brien J, Basile AM, Pantoni L, Inzitari D, Waldemar G, on behalf of the LADIS study group. Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging 2007;28:955-963. Scheltens P. All patients with suspected dementia should be scanned at least once with CT or MRI. Int Psychogeriatr 2007;19:533-534. Scheltens P. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer’s dissease. J Neurol Neurosurg Psychiatry 2007;78:1039. Scher AI, Xu Y, Korf ESC, White LR, Scheltens P, Toga AW, Thompson PM, Hartley SW, Witter MP, Valentino DJ, Launer LJ. Hiippocampal shape analysis in Alzheimer´s disease: a population-based study. Neuroimage 2007;36:8-18. Scherder EJA, Vuijk P-J, Swaab DF, van Someren EJW. Estimating the effects of right median nerve stimulation on memory in Alzheimer’s disease: a randomized controlled pilot study. Exp Aging Res 2007;33:177-186. Scholten, RJPM, Mink van der Molen A, Uitdehaag BMJ, Bouter LM, de Vet HCW. Surgical treatment options for carpal tunnel syndrome.(Review) Cochrane Database Syst Rev 2007;4:CD003905. Schuitemaker A, van Berckel BNM, Kropholler MA, Kloet RW, Jonker C, Scheltens P, Lammertsma AA, Boellaard R. Evaluation of methods for generating parametric (R)-[11C]PK11195 binding images. J Cereb Blood Flow Metab 2007;27:1603-1615. Schuitemaker A, van Berckel BNM, Kropholler MA, Veltman DJ, Scheltens P, Jonker C, Lammertsma AA, Boellaard R. SPM analysis of parametric (R)-[11C] PK11195 binding images: plasma input versus reference tissue parametric methods. Neuroimage 2007;35:1473-1479. Sikkes SAM, de Lange- de Klerk ESM, Pijnenburg YAL. Instrumental activities of daily living in the screening of dementia in population studies: comment on Castlla-Rilo et al. (2007) Int J Geriatr Psychiatry 2007;22:934-935. van Someren EJW. Improving actigraphic sleep estimates in insomnia and dementia: how many nights? J Sleep Res 2007;16:269-275. van Someren EJW, Nagtegaal E. Improving melatonin circadian phase estimates. Sleep Med 2007;8:590-601. van Someren EJW, Riemersma-van der Lek RF. Live to the rhythm, slave tot the rhythm. Sleep Med Rev 2007;11:465-484. van Someren EJW. Melatonin treatment efficacy: for whom and for what ?

Pagina 9 van 17

Sleep Med 2007;8:193-195. van Someren EJW. Thermoregulation and aging. Am J Physiol Regul Integr Comp Physiol 2007;292:R99-R102. Soon D, Altmann DR, Fernando KTM, Giovannoni G, Barkhof F, Polman CH, O’Connor P, Gray B, Panzara M, Miller DH. A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. J Neurol 2007;254:306-314. Stam CJ, Reijneveld JC. Graph theoretical analysis of complex networks in the brain. Nonlinear Biomedical Physics 2007;1: 3 (1-19) Stam CJ, Nolte G, Daffertshofer A. Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources. Hum Brain Mapp 2007;28:1178-1193. Stam CJ, Jones BF, Nolte G, Breakspear M, Scheltens Ph. Small-world networks and functional connectivity in Alzheimer’s disease. Cereb Cortex 2007;17:92-99. van Stegeren AH, Wolf OT, Everaerd W, Scheltens P, Barkhof F, Rombouts SARB. Endogenous cortisol level interacts with noradrenergic activation in the human amygdala. Neurobiol Learn Mem 2007;87:57-66. Stek ML, van der Wurff FB, Uitdehaag BMJ, Beekman ATF, Hoogendijk WJG. ECT in the treatment of depressed elderly: lessons from a terminated clinical trial. Int J Geriatr Psychiatry 2007;22:1052-1054. Stoffers D, Bosboom JLW, Deijen JB, Wolters EC, Berendse HW, Stam CJ. Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain 2007;130:1847-1860. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, Huerga E, Miszkiel KA, Plant GT, Polman C, Rovaris M, Thompson AJ, Montalban X, Miller DH. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:677-686. Teodorczuk A, O’Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund L-O, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bäzner H, Inzitari D on behalf of the LADIS Group. White matter changes and late-life depressive symptoms; longitudinal study. Br J Psychiatry 2007;191:212-217. Teunissen CE, Killestein J, Giovannoni G. Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity Biomarkers Med 2007;1:111-119. Teunissen CE, Scheltens P. Use of proteomic approaches to identify disease biomarkers. Lancet Neurol 2007;6:1036-1037. van Veen T, Nielsen J, Berkhof J, Barkhof F, Kamphorst W, Bö L, Ravid R, Verweij CL, Huitinga I, Polman CH, Uitdehaag BMJ. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis. J Neuroimmunol 2007;190:157-164. Verdelho A, Madureira S, Ferro JM, Basile A-M, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O’Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D on behalf of the LADIS study. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry 2007;78:1325-1330. Visser PJ, Kester A, Jolles J, Verhey F. Reply from the authors:Ten-year risk of dementia in subjects with mild cognitive impairment.

Pagina 10 van 17

Neurology 2007;68:1239. Vitatops Trial Study Group (waaronder o.a. Koedam E ) VITATOPS, the VITAmins TO Prevent Stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444) Int J Stroke 2007;2:144-150. van der Vlies AE, Pijnenburg YAL, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. Cognitive impairment in Alzheimer’s disease is modified by APOE genotype. Dement Geriatr Cogn Disord 2007;24:98-103. Vogels RLC, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 2007;9:1003-1009. Vogels RLC, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007;9:440-449. Vogels RLC, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007;24:418-423. Vogels RLC, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, Weinstein HC. Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc 2007;55:1764-1770. Vos MJ, Tony BN, Hoekstra OS, Postma TJ, Heimans JJ, Hooft L. Systematic review of the diagnostic accuracy of 201 TI single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun 2007;28:431-439. Vrenken H, Pouwels PJW, Ropele S, Knol DL, Geurts JJG, Polman CH, Barkhof F, Castelijns JA. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Mult Scler 2007;13:708-716. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14:e1-e26. van der Werf YD, Berendse HW, van Someren EJW, Stoffers D, Stam CJ, Wolters ECh. Observations on the cortical silent period in Parkinson’s disease. J Neural Transm 2007;(suppl.72):155-158. Wessels AM, Rombouts SARB, Remijnse PL, Boom Y, Scheltens P, Barkhof F, Heine RJ, Snoek FJ. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 2007;50:1763-1769. Wessels AM, Pouwer F, Geelhoed-Duijvestijn PHLM, Snel M, Kostenset PJ, Scheltens P, Heine RJ, Snoek FJ. No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional study. Diabet Med 2007;24:735-740. Willemse RB, de Munck JC, van't Ent D, Ris P, Baayen JC, Stam CJ, Vandertop WP. Magnetoencephalographic study of posterior tibial nerve stimulation in patients with intracranial lesions around the central sulcus. Neurosurgery 2007;61:1209-1217. van Winsen LML, Hooper-van Veen T, van Rossum EFC, Koper JW, Barkhof F, Polman CH, Uitdehaag BMJ. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.

Pagina 11 van 17

J Neuroimmunol 2007;186:150-155. Wolters, ECh. (Guest ed.), Abstracts of the XVII WFN World Congress on Parkinson’s disease and Related Disorders 9-13 December 2007. Amsterdam, The Netherlands. Parkinsonism Relat Disord 2007;13(suppl.2): 204 pp. Wolters ECh. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson’s disease. Parkinsonism Relat Disord 2007;13(suppl.1):S18-S23. Wolters ECh. Introduction. Parkinsonism Relat Disord 2007;13(suppl.1):S1. Wolters ECh (Ed). Parkinson’s disease: from premotor symptoms to new treatments strategies Parkinsonism Relat Disord 2007;13(suppl.1): 28 pp. Wolters ECh, Berendse HW, de Koning-Tijssen MAJ. (Guest eds). Proceedings of the XVII WFN World Congress on Parkinson’s disease and Related Disorders 9-13 December 2007. Amsterdam, The Netherlands. Parkinsonism Relat Disord 2007;13(suppl.3): 303 pp. Yaqub M, Boellaard R. van Berckel BNM, Ponssen MM, Lubberink M, Windhorst AD, Berendse HW, Lammertsma AA. Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography. J Cereb Blood Flow Metab 2007;27:1397-1406. Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T on behalf of the LADIS Study Group. Comparison of the Alzheimer’s disease assessment scale cognitive subscale and the vascular dementia assessment scale in differentiating elderly individuals with different degrees of white matter changes. Dement Geriatr Cogn Disord 2007;24:73-81. Vakpublicaties, boeken en ingezonden brieven: Bastos Leite AJ, Barkhof F, Scheltens P. Structural brain imaging. In: Gauthier S.(ed), Clinical diagnosis and management of Alzheimer’s disease; 3rd ed. Oxford, Informa Healthcare, 2007:81-95. Berendse HW, Booij J, Leenders KL. Neuroimaging in movement disorders: PET and SPECT. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:505-521. Berendse HW, van Laar T. Tremor. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:309-325. Boesveldt S, Berendse HW. Reukstoornissen bij de ziekte van Parkinson. Tijdschr Neuropsychiatrie & Gedragsneurologie 2007;6(1):4-8. Boesveldt S, Berendse HW. Reukstoornissen bij de ziekte van Parkinson. Patient Care Neuropsychiatrie; belgische editie 2007;(juli):21-25. Booij J, Berendse HW. Onderscheid tussen medicatie-geïnduceerd parkinsonisme en de ziekte van Parkinson. Tijdschr Neuropsychiatrie & Gedragsneurologie 2007;6(2):45-47. Bralten L, van Dijk K. Hallucinaties en de ziekte van Parkinson. Papaver 2007;30(nr.1):13-14. de Bruin AM, Nijman BC, Caljouw MF, Visser MC, Koole GM. Bedden beter bezet.

Pagina 12 van 17

Zorgvisie 2007;4:29. de Bruin AM, Nijman BC, Caljouw MF, Visser MC, Koole GM. De grootte van zorgeenheden: een logistieke benadering. Zorgvisie 2007:1-10. (www.zorgvisie.nl) Candelise L, Hughes R, Liberati A, Uitdehaag BMJ, Warlow Ch.(Eds), Evidence-based neurology: management of neurological disorders. Malden, Blackwell Publishing, 2007.276 pp. Dozy J, van der Flier WM, Pijnenburg YAL,Scheltens Ph, Weinstein HC (red.) Dementie handboek. Een beknopte leidraad voor de praktijk; 5e dr. Utrecht, Academic Pharmaceutical Productions bv, 2007. 158 pp. van der Flier W, Scheltens P. Speurtocht naar de oorzaak van geheugenverlies. In: van Aken WG, et al. (red.), Vergrijzend brein - wat ouder wordende hersenen met cognitieve vermogens doen. Den Haag, Bio-Wetenschappen en Maatschappij, 2007:61-66. (Cahier 3 / 2007-26e jaargang.) Foncke E. Ballism. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:401-404. Hovestadt A, Berendse HW, Bloem BR, Boon AJW, van Hilten JJ, de Koning-Tijssen MAJ, van Laar T, Nijssen PCG, Weber WEJ. ‘Nieuwe” middelen voor de behandeling van de ziekte van Parkinson. Tschr Neurol Neurochir 2007;108:240-244. Jelles B. Commentaar: Antistoffen tegen Interferon-beta. HealthDirect Neurologie 2007;3(6):27. Jelles B. Commentaar: Beloop MS idem als bij aangedaan familielid ? HealthDirect Neurologie 2007;3(3):27. Jelles B. Commentaar: Bestaat benigne MS eigenlijk wel ? HealthDirect Neurologie 2007;3(5):27. Jelles B. Commentaar: Betrouwbaar onderzoek naar effectiviteit zonder RTC? HealthDirect Neurologie 2007;3(6):25. Jelles B. Commentaar: Cannabisgebruik bij spasmes veroorzaakt door MS. HealthDirect Neurologie 2007;3(5):25. Jelles B. Commentaar: Cognitieve problemen bij MS al in vroege fase. HealthDirect Neurologie 2007;3(5):27. Jelles B. Commentaar: Genetisch identiek, kans op MS gecorreleerd aan zongedrag. HealthDirect Neurologie 2007;3(6):27. Jelles B. Commentaar: Mogelijjk verband tussen mononucleosis infectiosa en MS. HealthDirect Neurologie 2007;3(2):27. Jelles, B. Commentaar: MS, cortex en cognitie. HealthDirect Neurologie 2007;3(1):26-27. Jelles B. Commentaar: Prognostische factoren voor breinatrofie bij MS. HealthDirect Neurologie 2007;3(3):25. Jelles B. Commentaar: Relatie vitamine D en MS. HealthDirect Neurologie 2007;3(2):25. Killestein J, van der Voort LF, Polman CH. Reactie op ingezonden brief van drs. J.P. Schipper. Tschr Neurol Neurochir 2007;108:275.

Pagina 13 van 17

Koedam ELGE, Scheltens Ph. Referaat: Een mediterraan dieet verlaagt de kans op de ziekte van Alzheimer. Ned Tijdschr Geneeskd 2007;151:440. Koelman JHTM, van Rootselaar AF, Berendse HW, Stam CJ. Clinical neurophysiology in related disorders. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:537-550. Liedorp M, Vandertop WP, Scheltens Ph. De Tarlovse cyste: onbekend en onbelangrijk ? Tschr Neurol Neurochir 2007;108:234-239. Liedorp M, Eshghi S, Roesdi MF, Visser MC. Uw diagnose ? Tschr Neurol Neurochir 2007;108:198-199. Meijer JH, Boesveldt S, Elbertse E, Berendse HW. Using time interval parameters from impedance cardiography to evaluate autonomic nervous function in Parkinson’s disease. In: Scharfetter H, Merva R. (eds), 13th International Conference on Electrical Bioimpedance and the 8th Conference on Electrical Impedance Tomography.Berlin Heidelberg, Springer, 2007:596-599. (IFMBE Proceedings volume 17) Pijnenburg YAL. Commentaar: Alzheimer: nieuwe criteria. HealthDirect Neurologie 2007;3(6):19. Pijnenburg YAL. Commentaar: Conversie van MCI naar dementie: welke factoren spelen een rol? HealthDirect Neurologie 2007;3(2):19. Pijnenburg YAL. Commentaar: FAB: een geschikt screeningsinstrument ? HealthDirect Neurologie 2007;3(3):18. Pijnenburg YAL. Commentaar: Hersenbiopt: diagnostisch hulpmiddel bij snelprogressieve dementie. HealthDirect Neurologie 2007;3(3):20. Pijnenburg YAL. Commentaar: 100 jaar ziekte van Alzheimer. HealthDirect Neurologie 2007;3(1):17-18. Pijnenburg YAL. Commentaar: Intracereebrale pathologie met PET markers. HealthDirect Neurologie 2007;3(5):19. Pijnenburg YAL. Frontotemporale dementie: overzicht en recente ontwikkelingen. Tijdschr Neuropsychiatrie & Gedragsneurologie 2007;6:93-97. Pijnenburg YAL. Proefschriftbespreking: Frontotemporale dementie: op weg naar een vroege diagnose. Tschr Neurol Neurochir 2007;108:302-304. Pijnenburg YAL, van Swieten JC. Frontotemporal dementia with parkinsonism In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:283-288. van de Pol LA. Proefschriftbespreking: Hippocampusatrofie op MRI, van veroudering tot dementie. Tschr Neurol Neurochir 2007;108:252-254. Reijneveld JC. Acuut bewustzijnsverlies en later verwardheid ten gevolge van een subarachnoïdale bloeding. Utrechts Tijdschr Neurol 2007;65:17-18. Een eenmalige uitgave ter gelegenheid van het afscheid van prof.dr. J. van Gijn van de afd, Neurologie van het Universitair Medisch Centrum Utrecht. Rombouts SARB, Barkhof F, Scheltens P (eds), Clinical applications of functional brain MRI. Oxford, Oxford University Press, 2007. 386 pp. Scheltens P. Advances in neuroimaging.

Pagina 14 van 17

In: Growdon JH, Rossor MN. (vol. eds), The Dementias 2. Philadelphia, Butterworth Heinemann Elsevier, 2007:381-410. Schoonenboom SNM, Bouwman FH, Scheltens Ph. Hoort liquoronderzoek thuis in de diagnostiek van (beginnende) dementie? Tschr Neurol Neurochir 2007;108:228-233. Staekenborg SS, Scheltens P. Foliumzuursuppletie verbetert cognitief functioneren bij ouderen. Ned Tijdschr Geneeskd 2007;151:1544. Stam CJ, Berendse HW, Koelman JHTM. Clinical neurophysiology in parkinsonism. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:523-536. Stam, C.J. Electrophysiological tests. In: Gauthier S.(ed), Clinical diagnosis and management of Alzheimer’s disease; 3rd ed. Oxford, Informa Healthcare, 2007:111-123. Stam CJ. Journal scan: Bijdrage van ultrageluid in een neurofysiologisch laboratorium aan de diagnostiek van perifeer zenuwstelsel: een eenjarig systematisch onderzoek. Bron: Padua L et al. Contribution of ultrasound in a neurophysiological lab in diagnosing nerve impairment: a one-year systematic assessment. Clin Neurophysiol 2007;118;1410-1416. Tschr Neurol Neurochir 2007;108:247-248. Stam CJ. Journal scan: Een gerandomiseerde klinische studie naar repetitieve transcraniële magnetische stimulatie bij patiënten met refractaire epilepsie. Bron: Fregni F et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy. Ann Neurol 2006;60:447-455. Tschr Neurol Neurochir 2007;108:89-90. Uitdehaag BMJ, Jelles B, Killestein J, van Oosten BW, Polman CH. Ingezonden: Immuunmodulerende medicatie bij multiple sclerose. Ned Tijdschr Geneeskd 2007;151:1435. Uitdehaag BMJ. Journal scan: Het beloop van ‘relapsing-remitting’ multiple sclerose onder behandeling met interferon-bèta. Bron: Trojano M et al. New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 2007;61:300-306. Tschr Neurol Neurochir 2007;108:391-392. Uitdehaag BMJ. Neurologische complicaties bij schildklierlijden. In: Biemond Cursus: Consultative neurologie, vrijdag 16 maart 2007 te Arnhem en vrijdag 14 december 2007 te Veldhoven. Utrecht, Nederlandse Vereniging voor Neurologie, 2007:28-38. Uitdehaag BMJ, Rothwell PM. Systematic reviews of diagnostic research. In: Candelise L, Hughes R, Liberati A, Uitdehaag BMJ, Warlow Ch. (eds), Evidence-based neurology: management of neurological disorders. Malden, Blackwell Publishing, 2007:23-26. Vergouwen MDI, Kwa VIH, Weinstein HC, Imanse JG, Visser MC, Stam J. Trombolyse bij acute herseninfarcten-implementatie van een nieuwe therapie. Tschr Neurol Neurochir 2007;108:57-62. Verheij FRJ, Ramakers I, Jolles J, Scheltens Ph, Vernooij-Dassen M, Olde Rikkert M. Geheugenpoli’s in Nederland: ontwikkelingen sinds 1998. Tijdschr Gerontol Geriatr 2007;38:237-245. Verheij FRJ, Scheltens Ph, Olde Rikkert MGM. De ontwikkeling van geheugenpoliklinieken in Nederland. Ned Tijdschr Geneeskd 2007;151:578-580. Visser MC. Niet zomaar een myotonie. Utrechts Tijdschr Neurol, 2007;65:15-16. Een eenmalige uitgave ter gelegenheid van het afscheid van prof.dr. J. van Gijn van de afd, Neurologie

Pagina 15 van 17

van het Universitair Medisch Centrum Utrecht. Visser PJ. Boekbespreking: HA Tuokko, DF Hultsch(red), Mild cognitive impairment: international perspectives. Philadelphia, Psychology Press, 2006. Tijdschr Neuropsychol 2007;(3):53-54. van der Vlies A, Pijnenburg Y, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. APOE-genotype beïnvloedt cognitie in ziekte van Alzheimer. Tijdschr Neuropsychol 2007;2:20-29. van der Voort LF, Schellekens H, Oudejans CBM, Blankenstein MA, Polman CH, Killestein J. Neutraliserende antilichamen tegen interferon-bèta bij multipele sclerose. Tschr Neurol Neurochir 2007;108:108-113. Vos MJ, Postma TJ, Heimans JJ. Monitoring van het effect van therapie bij patiënten met een glioom. Tschr Neurol Neurochir 2007;108:356-361. de Weerd AW, Wolters ECh. Restless legs syndrome. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:405-411. Winogrodzka A, Wolters ECh. Tolcapon bij de behandeling van de ziekte van Parkinson: terug van weggeweest. Neurologie Actueel 2007;10:nr.7. Wolters ECh. Parkinsonisme. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:131-142. Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007. 576 pp. Wolters ECh, Bosboom JLW. Parkinson’s disease. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:143-158. Wolters ECh, Stoffers D, Bosboom JLW. Parkinson’s disease - related cognitive impairment and dementia (PDD and DLB). In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:191-201. Wolters ECh. Psychiatric movement disorders. In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:429-444.

Pagina 16 van 17

Publicaties bijzondere hoogleraren: Anderson VM, Fernando KTM, Davies GR, Rashid W, Frost C, Fox NC, Miller DH. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 2007;17:61-68. Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates. J Neurol 2007;254:1588-1594. Archer HA, McFarlane F, Frost C, Cutler D, Fox NC, Rossor MN. Symptoms of memory loss as predictors of cognitive impairment ? The use and reliability of memory ratings in a clinic population. Alzheimer Dis Assoc Disord 2007;21:101-106. Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, Fox NC. Automatic calculation of hiippocampal atrophy rates using a hippocampal template and the boundary shoft integral. Neurobiol Aging 2007;28:1657-1663. Barnes J, Lewis EB, Scahill RI, Bartlett JW, Frost C, Schott JM, Rossor MN, Fox NC. Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. J Comput Assist Tomogr 2007;31:581-587. Barnes J, Foster J, Fox NC. Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease Biomarkers Med 2007;1:79-92. Camara O, Scahill RI, Schnabel JA, Crum WR, Ridgway GR, Hill DLG, Fox NC. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal data. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2007;10(Pt2):785-792. Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J. Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates. Am J Psychiatry 2007;164:916-921. Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition in Alzheimer disease; an [11C] PIB and [18F] FDG PET study. Neurology 2007;68:501-508. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, Del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6:501-512. Mauer MEL, Taphoorn MJB, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, van der Rijt CCD, Bernsen HJJA, Frénay M, Tijssen CC, Lacombe D, van den Bent MJ. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC Brain Cancer Group Study J Clin Oncol 2007;36:5731-5737. Paviour DC, Price SL, Lees AJ, Fox NC. MRI derived brain atrophy in PSP and MSA-P: determining sample size to detect treatment effects. J Neurol 2007;254:478-481. Petzold A, Keir G, Warren J, Fox N, Rossor MN. A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegeneration 2007;4:185-194.

Pagina 17 van 17

Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS. Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007;28:965-970. Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, MacManus DG, Rossor MN, Fox NC, Tofts PS. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007;244:832-837. Scahill RI, Fox NC. Longitudinal imaging in dementia. Br J Radiol 2007;80(spec.no.2):S92-S98. Smith SM, Rao A, De Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007;36:1200-1206. Taphoorn MJB, van den Bent MJ, Mauer MEL, Coens C, Delattre J-Y, Brandes AA, Sillevis Smitt PAE, Bernsen HJJA, Frénay M, Tijssen CC, Lacombe D, Allgeier A, Bottomley A. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial J Clin Oncol 2007;36:5723-5730. Taphoorn MJB. Neurotoxiciteit: de keerzijde van hersentumorbehandeling; editorial bij de bijdrage van SE Korsse, CA van Es en PH Wessels. Tschr Neurol Neurochir 2007;108:381-382. Whitwell JL, Sampson EL, Loy CT, Warren JE, Rossor MN, Fox NC, Warren JD. VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage 2007;35:207-213.